Zorgstandaard Neurofibromatose Type 1

98 / 113

98
[148] T. Colás-Tomás, E. Gutiérrez-Díaz, P. Tejada-Palacios, A. Barceló-Mendiguchía, and E. Mencía-
Gutiérrez, “Management of congenital glaucoma in neurofibromatosis type 1: a report of two cases,”
Int. Ophthalmol., vol. 30, no. 2, pp. 211–214, Apr. 2010.
[149] W. M. Grant and D. S. Walton, “Distinctive gonioscopic findings in glaucoma due to
neurofibromatosis,” Arch. Ophthalmol., vol. 79, no. 2, pp. 127–134, Feb. 1968.
[150] European Glaucoma Society, “Terminology and guidelines for glaucoma.” 2003.
[151] S. Goktas, Y. Sakarya, M. Ozcimen, I. Alpfidan, M. Uzun, R. Sakarya, and A. Yarbag, “Frequency of
Choroidal Abnormalities in Pediatric Patients With Neurofibromatosis Type 1,” J. Pediatr. Ophthalmol.
Strabismus, pp. 1–5, May 2014.
[152] T. Yasunari, K. Shiraki, H. Hattori, and T. Miki, “Frequency of choroidal abnormalities in
neurofibromatosis type 1,” Lancet, vol. 356, no. 9234, pp. 988–992, Sep. 2000.
[153] F. Viola, E. Villani, F. Natacci, A. Selicorni, G. Melloni, D. Vezzola, G. Barteselli, C. Mapelli, C. Pirondini,
and R. Ratiglia, “Choroidal Abnormalities Detected by Near-Infrared Reflectance Imaging as a New
Diagnostic Criterion for Neurofibromatosis 1,” Ophthalmology, vol. 119, no. 2, pp. 369–375, Feb. 2012.
[154] Samenwerkende oogcentra van de Samenwerkende Topklinische Ziekenhuizen, “Scheelzien
(strabismus) en operatie.” [Online]. Available:
[Accessed:
10-Jul-2014].
[155] A. G. de A. Campomanes, R. A. Avery, S. Prasad, and G. T. Liu, “Myopia associated with optic nerve
gliomas in neurofibromatosis type 1,” J. AAPOS Off. Publ. Am. Assoc. Pediatr. Ophthalmol. Strabismus
Am. Assoc. Pediatr. Ophthalmol. Strabismus, vol. 16, no. 1, pp. 89–91, Feb. 2012.
[156] J. Y. Chen, J. S. Muecke, and S. D. Brown, “Orbital plexiform neurofibroma and high axial myopia,”
Ophthal. Plast. Reconstr. Surg., vol. 24, no. 4, pp. 284–286, Aug. 2008.
[157] B. Z. Garty, A. Laor, and Y. L. Danon, “Myopia in neurofibromatosis type 1,” Isr. J. Med. Sci., vol. 32,
no. 5, pp. 297–299, May 1996.
[158] Samenwerkende oogcentra van de Samenwerkende Topklinische Ziekenhuizen, “Bijziendheid
(myopie).” [Online]. Available:
[Accessed: 10-Jul-2014].
[159] I. A. Chaudhry, J. Morales, F. A. Shamsi, W. Al-Rashed, E. Elzaridi, Y. O. Arat, C. Jacquemin, D. T.
Oystreck, and T. M. Bosley, “Orbitofacial neurofibromatosis: clinical characteristics and treatment
outcome,” Eye, vol. 26, no. 4, pp. 583–592, Apr. 2012.
[160] NOG, Bartiméus, and Koninklijke Visio, “Richtlijn visusstoornissen, revalidatie en verwijzing.” 2004.
[161] K. A. Diggs-Andrews and D. H. Gutmann, “Modeling cognitive dysfunction in neurofibromatosis-1,”
Trends Neurosci., vol. 36, no. 4, pp. 237–247, Apr. 2013.
[162] D. S. Feldman, C. Jordan, and L. Fonseca, “Orthopaedic manifestations of neurofibromatosis type 1,”
J. Am. Acad. Orthop. Surg., vol. 18, no. 6, pp. 346–357, Jun. 2010.
[163] Vereniging Bewegingsleer Cesar, “Richtlijn idiopathische scoliose.” Jun-2004.
[164] T. Greggi and K. Martikos, “Surgical treatment of early onset scoliosis in neurofibromatosis,” Stud.
Health Technol. Inform., vol. 176, pp. 330–333, 2012.
[165] CBO and Nederlandse Vereniging voor Reumatologie, “Osteoporose en Fractuurpreventie.” 2011.
[166] Koninklijk Nederlands Genootschap voor Fysiotherapie, “KNGF-richtlijn Osteoporose.” 2011.
[167] M. Hivelin, P. Wolkenstein, C. Lepage, L. Valeyrie-Allanore, J. P. Meningaud, and L. Lantieri, “Facial
aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: report on 33
consecutive adult patients,” Plast. Reconstr. Surg. , vol. 125, no. 4, pp. 1197–1207, Apr. 2010.
[168] E. A. Soucy, D. van Oppen, N. L. Nejedly, F. Gao, D. H. Gutmann, and A. S. Hollander, “Height
assessments in children with neurofibromatosis type 1,” J. Child Neurol., vol. 28, no. 3, pp. 303–307,
Mar. 2013.
[169] S. J. Howell, P. Wilton, A. Lindberg, and S. M. Shalet, “Growth hormone and neurofibromatosis,”
Horm. Res., vol. 53 Suppl 1, pp. 70–76, 2000.